Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-13 00:15 | 2024-02-08 | RXO | RXO, Inc. | MFN Partners, LP | 10% owner | Transportation Services | BUY | $20.67 | 1,832,906 | $37,879,385 | 15,588,555 | +13.3% |
| 2024-02-13 02:06 | 2024-02-08 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $16.98 | 254,539 | $4,323,090 | 26,192,081 | +1.0% |
| 2024-02-13 01:57 | 2024-02-08 | BMEZ | BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $15.96 | 287,880 | $4,594,248 | 19,148,163 | +1.5% |
| 2024-02-13 01:54 | 2024-02-08 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $8.18 | 719,359 | $5,882,558 | 48,191,447 | +1.5% |
| 2024-02-13 02:23 | 2024-02-08 | JSPR | Jasper Therapeutics, Inc. | Carlyle Group Inc. | Other | Biological Products, (No Diagnostic Substances) | BUY | $12.95 | 190,000 | $2,460,500 | 1,066,189 | +21.7% |
| 2024-02-13 01:46 | 2024-02-08 | SANA | Sana Biotechnology, Inc. | NELSEN ROBERT | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $5.50 | 1,818,181 | $9,999,996 | 12,446,022 | +17.1% |
| 2024-02-13 01:43 | 2024-02-08 | SANA | Sana Biotechnology, Inc. | CRANDELL KEITH | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $5.50 | 1,818,181 | $9,999,996 | 12,446,022 | +17.1% |
| 2024-02-12 17:05 | 2024-02-09 | VFC | V F CORP | Darrell Bracken | Director, Officer - President & Chief Exec Officer | Men's & Boys' Furnishgs, Work Clothg, & Allied Garments | BUY | $15.38 | 65,360 | $1,005,296 | 144,281 | +82.8% |
| 2024-02-10 04:40 | 2024-02-08 | JSPR | Jasper Therapeutics, Inc. | Velan Capital Investment Management LP | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $12.95 | 350,000 | $4,532,500 | 1,188,500 | +41.7% |
| 2024-02-10 02:28 | 2024-02-07 | AON | Aon plc | KNIGHT LESTER B | Director | Insurance Agents, Brokers & Service | BUY | $301.97 | 50,000 | $15,098,480 | 50,000 | +100.0% |
| 2024-02-09 00:37 | 2024-02-06 | GUTS | FRACTYL HEALTH, INC. | Royan Ajay | Director, 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $15.00 | 333,333 | $4,999,995 | 1,251,900 | +36.3% |
| 2024-02-09 00:32 | 2024-02-06 | GUTS | FRACTYL HEALTH, INC. | Elia Marc | Director | Surgical & Medical Instruments & Apparatus | BUY | $15.00 | 466,666 | $6,999,990 | 1,856,117 | +33.6% |
| 2024-02-09 00:32 | 2024-02-06 | ANRO | Alto Neuroscience Inc. | Alpha Wave Global, LP | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 600,000 | $9,600,000 | 3,707,757 | +19.3% |
| 2024-02-08 19:37 | 2024-02-06 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $16.70 | 181,231 | $3,027,373 | 25,937,542 | +0.7% |
| 2024-02-08 19:33 | 2024-02-06 | BMEZ | BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $15.77 | 170,224 | $2,684,262 | 18,860,283 | +0.9% |
| 2024-02-08 19:31 | 2024-02-06 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $7.82 | 615,159 | $4,811,651 | 47,472,088 | +1.3% |
| 2024-02-09 04:11 | 2024-02-06 | KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $14.62 | 86,048 | $1,257,832 | 4,824,731 | +1.8% |
| 2024-02-09 02:58 | 2024-02-06 | LCTX | Lineage Cell Therapeutics, Inc. | BROADWOOD PARTNERS, L.P. | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $1.04 | 6,730,770 | $7,000,001 | 41,666,255 | +19.3% |
| 2024-02-09 00:35 | 2024-02-06 | GUTS | FRACTYL HEALTH, INC. | Mithril LP | 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $15.00 | 333,333 | $4,999,995 | 1,251,900 | +36.3% |
| 2024-02-08 02:36 | 2024-02-05 | CRMT | AMERICAS CARMART INC | Peterson Adam K | 10% owner | Retail-Auto Dealers & Gasoline Stations | BUY | $60.20 | 42,149 | $2,537,538 | 673,200 | +6.7% |
| 2024-02-08 01:09 | 2024-02-07 | OPK | OPKO HEALTH, INC. | FROST PHILLIP MD ET AL | Director, Officer, 10% owner - CEO & Chairman | Pharmaceutical Preparations | BUY | $0.98 | 1,500,000 | $1,462,800 | 207,368,225 | +0.7% |
| 2024-02-08 00:10 | 2024-02-07 | NEE | NEXTERA ENERGY INC | HACHIGIAN KIRK S | Director | Electric Services | BUY | $55.84 | 20,000 | $1,116,700 | 25,000 | +400.0% |
| 2024-02-08 00:12 | 2024-02-06 | CHTR | CHARTER COMMUNICATIONS, INC. /MO/ | Winfrey Christopher L | Director, Officer - President and CEO | Cable & Other Pay Television Services | BUY | $295.29 | 5,050 | $1,491,215 | 57,703 | +9.6% |
| 2024-02-07 00:00 | 2024-02-02 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Cormorant Asset Management, LP | 10% owner | Pharmaceutical Preparations | BUY | $19.00 | 750,000 | $14,250,000 | 1,475,000 | +103.4% |
| 2024-02-07 00:13 | 2024-02-02 | RXO | RXO, Inc. | MFN Partners, LP | 10% owner | Transportation Services | BUY | $20.25 | 747,424 | $15,135,336 | 13,755,649 | +5.7% |
| 2024-02-07 04:39 | 2024-02-06 | GUTS | FRACTYL HEALTH, INC. | CVF, LLC | 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $15.00 | 333,333 | $4,999,995 | 4,673,870 | +7.7% |
| 2024-02-06 01:50 | 2024-02-02 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $16.49 | 203,346 | $3,352,423 | 25,756,311 | +0.8% |
| 2024-02-06 01:46 | 2024-02-02 | BMEZ | BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $15.57 | 147,429 | $2,296,133 | 18,690,059 | +0.8% |
| 2024-02-06 01:44 | 2024-02-02 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $7.76 | 148,641 | $1,152,889 | 46,856,929 | +0.3% |
| 2024-02-05 22:13 | 2024-02-01 | N/A | N/A | Golub Lawrence E | Director, Officer, 10% owner - CHAIRMAN | Other | BUY | $15.00 | 300,032 | $4,500,473 | 3,673,577 | +8.9% |
| 2024-02-05 22:14 | 2024-02-01 | N/A | N/A | Golub David | Director, Officer, 10% owner - President, CEO | Other | BUY | $15.00 | 300,032 | $4,500,473 | 3,673,577 | +8.9% |
| 2024-02-06 00:33 | 2024-02-01 | SMCI | Super Micro Computer, Inc. | CHAN SHIU LEUNG | Director | Electronic Computers | BUY | $568.00 | 2,000 | $1,136,000 | 42,917 | +4.9% |
| 2024-02-06 01:02 | 2024-02-01 | ATXS | Astria Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Pharmaceutical Preparations | BUY | $12.09 | 2,481,350 | $29,999,522 | 4,873,721 | +103.7% |
| 2024-02-06 05:30 | 2024-02-01 | OXY | OCCIDENTAL PETROLEUM CORP /DE/ | BERKSHIRE HATHAWAY INC | 10% owner | Crude Petroleum & Natural Gas | BUY | $57.15 | 4,302,324 | $245,879,968 | 248,018,128 | +1.8% |
| 2024-02-06 05:33 | 2024-02-01 | SNDA | SONIDA SENIOR LIVING, INC. | Levinson Sam | 10% owner | Services-Nursing & Personal Care Facilities | BUY | $9.50 | 1,052,632 | $10,000,004 | 1,923,277 | +120.9% |
| 2024-02-02 23:34 | 2024-02-01 | N-A | N/A | JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK | 10% owner | Other | BUY | $20.24 | 197,629 | $4,000,011 | 991,456 | +24.9% |
| 2024-02-03 00:15 | 2024-01-31 | N-A | N/A | Manulife Private Credit Plus Fund | 10% owner | Other | BUY | $20.74 | 723,237 | $14,999,935 | 2,167,787 | +50.1% |
| 2024-02-02 23:25 | 2024-02-01 | N-A | N/A | John Hancock Life & Health Insurance Co | 10% owner | Other | BUY | $20.24 | 197,629 | $4,000,011 | 991,456 | +24.9% |
| 2024-02-02 23:54 | 2024-02-01 | N-A | N/A | Manulife Reinsurance (Bermuda) LTD | 10% owner | Other | BUY | $20.24 | 494,071 | $9,999,997 | 2,478,639 | +24.9% |
| 2024-02-03 00:02 | 2024-02-01 | N-A | N/A | Manulife Private Credit Plus Fund | 10% owner | Other | BUY | $20.10 | 248,756 | $4,999,996 | 1,494,741 | +20.0% |
| 2024-02-02 17:15 | 2024-01-31 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $16.23 | 61,618 | $1,000,003 | 11,956,600 | +0.5% |
| 2024-02-02 17:08 | 2024-01-31 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $16.23 | 431,328 | $7,000,019 | 7,631,449 | +6.0% |
| 2024-02-02 17:01 | 2024-01-31 | N-A | N/A | Manulife (Singapore) Pte. Ltd. | 10% owner | Other | BUY | $16.23 | 1,910,166 | $31,000,084 | 6,028,981 | +46.4% |
| 2024-02-03 00:32 | 2024-01-31 | SKYE | Skye Bioscience, Inc. | 5AM Partners VII, LLC | 10% owner | Pharmaceutical Preparations | BUY | $2.31 | 5,206,074 | $12,026,031 | 7,943,520 | +190.2% |
| 2024-02-02 23:13 | 2024-02-02 | BBXIA-B | BBX Capital, Inc. | LEVAN JARETT | Director, Officer, 10% owner - CEO and President | Retail-Food Stores | BUY | $11.08 | 415,395 | $4,602,577 | 500,557 | +487.8% |
| 2024-02-02 23:45 | 2024-02-01 | N-A | N/A | JOHN HANCOCK LIFE INSURANCE CO USA | 10% owner | Other | BUY | $20.24 | 98,814 | $1,999,995 | 492,727 | +25.1% |
| 2024-02-02 00:01 | 2024-01-31 | N-A | N/A | Manulife Private Credit Plus Fund | 10% owner | Other | BUY | $20.74 | 723,237 | $15,000,000 | 1,444,550 | +100.3% |
| 2024-02-01 22:49 | 2024-01-31 | QNBC | QNB CORP. | Bimes Randy S. | Director | State Commercial Banks | BUY | $25.66 | 48,978 | $1,256,775 | 223,502 | +28.1% |
| 2024-02-01 23:47 | 2024-01-31 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $17.99 | 555,907 | $9,999,987 | 34,389,028 | +1.6% |
| 2024-02-02 00:11 | 2024-01-31 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $16.23 | 123,237 | $2,000,005 | 6,434,945 | +2.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.